StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Caplin Point Laboratories Limited
NSE:CAPLIPOINT.NS
Sector
Location
Market Cap
USD 1.85 B
Share Price
USD 24.42
Avg Daily Volume
135,219
Change (1 day)
1.44%
Change (1 year)
38.15%
Change (YTD)
-16.39%
Caplin Point Laboratories Limited EBT Margin for the year ending March 31, 2025: 34.93%
Caplin Point Laboratories Limited EBT Margin is 34.93% for the year ending March 31, 2025, a 3.77% change year over year. EBT Ratio (Earnings Before Tax Ratio) is the fraction of earnings before taxes to total revenue, indicating the company's profitability before the impact of tax expenses.
-
Caplin Point Laboratories Limited EBT Margin for the year ending March 31, 2024 was 33.66%, a 9.39% change year over year.
-
Caplin Point Laboratories Limited EBT Margin for the year ending March 31, 2023 was 30.77%, a 0.74% change year over year.
-
Caplin Point Laboratories Limited EBT Margin for the year ending March 31, 2022 was 30.55%, a 2.10% change year over year.
-
Caplin Point Laboratories Limited EBT Margin for the year ending March 31, 2021 was 29.92%, a -4.16% change year over year.
Competitors
Johnson & Johnson
USD 169.10
JNJ
+1.17
0.70%
Divi's Laboratories Limited
USD 77.04
DIVISLAB.NS
+0.46
0.60%
ALK-Abelló A/S
USD 30.25
ALK-B.CO
+0.43
1.43%
Nahdi Medical Company
USD 35.00
4164.SR
+1.01
2.98%
Rohto Pharmaceutical Co.,Ltd.
USD 14.58
4527.T
+0.30
2.07%
J. B. Chemicals & Pharmaceuticals Limited
USD 19.56
JBCHEPHARM.NS
+0.02
0.09%
Hypera S.A.
USD 4.79
HYPE3.SA
+0.14
3.07%
Almirall, S.A.
USD 12.38
ALM.MC
-0.06
-0.46%
Organon & Co.
USD 10.10
OGN
+0.28
2.85%
Dermapharm Holding SE
USD 40.65
DMP.DE
+0.81
2.03%
Eli Lilly and Company
USD 798.89
LLY
+22.45
2.89%
AbbVie Inc.
USD 190.55
ABBV
+3.44
1.84%
Roche Holding AG
USD 348.84
RO.SW
+11.26
3.33%
AstraZeneca PLC
USD 144.94
AZN.L
+4.91
3.51%
Merck & Co., Inc.
USD 83.98
MRK
+2.37
2.90%
Amgen Inc.
USD 309.22
AMGN
+3.53
1.16%
Pfizer Inc.
USD 25.36
PFE
+0.22
0.88%
Gilead Sciences, Inc.
USD 113.56
GILD
+3.39
3.08%
Sanofi
USD 99.61
SAN.PA
+2.58
2.66%
Key Data
| Date | EBT Margin | Operating Income Margin | Gross Profit Margin | EBIT Margin |
|---|
Competitors
Johnson & Johnson
USD 169.10
JNJ
+1.17
0.70%
Divi's Laboratories Limited
USD 77.04
DIVISLAB.NS
+0.46
0.60%
ALK-Abelló A/S
USD 30.25
ALK-B.CO
+0.43
1.43%
Nahdi Medical Company
USD 35.00
4164.SR
+1.01
2.98%
Rohto Pharmaceutical Co.,Ltd.
USD 14.58
4527.T
+0.30
2.07%
J. B. Chemicals & Pharmaceuticals Limited
USD 19.56
JBCHEPHARM.NS
+0.02
0.09%
Hypera S.A.
USD 4.79
HYPE3.SA
+0.14
3.07%
Almirall, S.A.
USD 12.38
ALM.MC
-0.06
-0.46%
Organon & Co.
USD 10.10
OGN
+0.28
2.85%
Dermapharm Holding SE
USD 40.65
DMP.DE
+0.81
2.03%
Eli Lilly and Company
USD 798.89
LLY
+22.45
2.89%
AbbVie Inc.
USD 190.55
ABBV
+3.44
1.84%
Roche Holding AG
USD 348.84
RO.SW
+11.26
3.33%
AstraZeneca PLC
USD 144.94
AZN.L
+4.91
3.51%
Merck & Co., Inc.
USD 83.98
MRK
+2.37
2.90%
Amgen Inc.
USD 309.22
AMGN
+3.53
1.16%
Pfizer Inc.
USD 25.36
PFE
+0.22
0.88%
Gilead Sciences, Inc.
USD 113.56
GILD
+3.39
3.08%
Sanofi
USD 99.61
SAN.PA
+2.58
2.66%